Cargando…
Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseases
Autores principales: | Ma, Alison Lap-Tak, Leung, Daniel, Chan, Eugene Yu-Hin, Chim, Stella, Cheng, Samuel, Ho, Fanny Tsz-Wai, Lai, Wai-Ming, Tong, Pak-Chiu, Lee, Matthew Hon-Lam, Wong, Wilfred Hing-Sang, Chan, Sau Man, Rosa Duque, Jaime, Peiris, Joseph Sriyal Malik, Lau, Yu Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881810/ https://www.ncbi.nlm.nih.gov/pubmed/35231464 http://dx.doi.org/10.1016/j.kint.2022.01.035 |
Ejemplares similares
-
Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases
por: Chan, Eugene Yu-Hin, et al.
Publicado: (2023) -
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases
por: Leung, Daniel, et al.
Publicado: (2023) -
Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis
por: Chan, Eugene Yu-hin, et al.
Publicado: (2022) -
Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases
por: Yu, Michael Kwan Leung, et al.
Publicado: (2023) -
Is respiratory viral infection really an important trigger of asthma exacerbations in children?
por: Lee, So-lun, et al.
Publicado: (2011)